SCHEMBL4616261

SCHEMBL4616261

Cn1c(=O)[nH]c2c(C(N)=O)cc(C[CH]C(=O)[N+]3(C4CCNCC4)CCCCC3)cc21

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PARP2 Q9UGN5 2/20 0.32
PARP3 Q9Y6F1 1/20 0.32
PARP1 P09874 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4593488 0.82
SCHEMBL4585952 0.80
SCHEMBL4593121 0.78 PLK4 (0.35) PARP1
SCHEMBL4593572 0.75 HTR3A (0.30)
SCHEMBL4593670 0.75 MAP3K5 (0.39)
SCHEMBL4593241 0.73 KDM4E (0.37) PARP2PARP3PARP1
SCHEMBL4593642 0.70 JAK2 (0.30)
SCHEMBL6135661 0.70 SLC6A2 (0.38)
SCHEMBL6135611 0.69
SCHEMBL4594181 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1689493-A4 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS BRISTOL MYERS SQUIBB CO (US) 2008-04-23 EP claimed
EP-1689493-A1 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS Bristol-Myers Squibb Pharma Company (US) 2006-08-16 EP claimed
WO-2005065779-A1 CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-07-21 WO claimed